AR042702A1 - Proceso para preparar aripiprazola - Google Patents
Proceso para preparar aripiprazolaInfo
- Publication number
- AR042702A1 AR042702A1 ARP040100006A ARP040100006A AR042702A1 AR 042702 A1 AR042702 A1 AR 042702A1 AR P040100006 A ARP040100006 A AR P040100006A AR P040100006 A ARP040100006 A AR P040100006A AR 042702 A1 AR042702 A1 AR 042702A1
- Authority
- AR
- Argentina
- Prior art keywords
- aripiprazole
- group
- compound represented
- aripiprazola
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Abstract
La presente comprende proceso para preparar aripiprazola con una pureza más elevada y un mayor rendimiento. De acuerdo con el proceso de la presente, la aripiprazola se prepara mediante la reacción de un compuesto carboestirilo representado por la fórmula general (1) (en donde X es un átomo de halógeno, grupo alcanosulfoniloxi inferior, grupo arilsulfoniloxi o un grupo aralquilsulfoniloxi, con un compuesto de piperazina representado por la fórmula (2), y/o una sal del mismo en agua, en presencia de 0,5 a 10 mol de un compuesto básico, inorgánico, por mol de compuesto carboestirilo (2). La aripiprazola se utiliza como agente antisicótico, en el tratamiento de la esquizofrenia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003002996 | 2003-01-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR042702A1 true AR042702A1 (es) | 2005-06-29 |
Family
ID=32652780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100006A AR042702A1 (es) | 2003-01-09 | 2004-01-05 | Proceso para preparar aripiprazola |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6995264B2 (es) |
| EP (1) | EP1480953B2 (es) |
| JP (2) | JP5797090B2 (es) |
| KR (1) | KR100583667B1 (es) |
| CN (1) | CN1263742C (es) |
| AR (1) | AR042702A1 (es) |
| AT (1) | ATE308524T1 (es) |
| AU (1) | AU2003288755C1 (es) |
| BR (2) | BR0305500A (es) |
| CA (2) | CA2458929C (es) |
| DE (1) | DE60302139T3 (es) |
| DK (1) | DK1480953T4 (es) |
| EG (1) | EG23557A (es) |
| ES (1) | ES2250919T5 (es) |
| HK (1) | HK1073110A1 (es) |
| MX (1) | MXPA04002519A (es) |
| MY (1) | MY129831A (es) |
| SI (1) | SI1480953T2 (es) |
| TW (1) | TWI258470B (es) |
| WO (1) | WO2004063162A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005058835A2 (en) * | 2003-12-16 | 2005-06-30 | Teva Pharmaceutical Industries Ltd. | Methods of preparing aripiprazole crystalline forms |
| US7714129B2 (en) * | 2003-12-16 | 2010-05-11 | Teva Pharmaceutical Industries Ltd. | Methods of preparing anhydrous aripiprazole form II |
| MXPA06008828A (es) * | 2004-02-05 | 2007-04-25 | Teva Pharma | Proceso para preparar aripiprazol. |
| US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
| KR101041551B1 (ko) * | 2004-10-08 | 2011-06-15 | 수벤 라이프 사이언시스 리미티드 | 아리피프라졸 제조를 위해 유용한 신규 중간체와 신규중간체 및 아리피프라졸 제조 방법 |
| US20060079689A1 (en) * | 2004-10-12 | 2006-04-13 | Vladimir Naddaka | Processes for preparing and purifying carbostyril compounds such as aripiprazole and 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones |
| EP1812397A1 (en) * | 2004-11-18 | 2007-08-01 | Synthon B.V. | Process of making crystalline aripiprazole |
| CN1303068C (zh) * | 2005-01-11 | 2007-03-07 | 中国人民解放军第二军医大学 | 一种阿立哌唑的制备方法 |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| JP2009508859A (ja) * | 2005-09-15 | 2009-03-05 | エラン ファーマ インターナショナル リミテッド | ナノ粒子アリピプラゾール製剤 |
| EP1919453A2 (en) * | 2005-12-22 | 2008-05-14 | Teva Pharmaceutical Industries Ltd | Processes for reducing particle size of aripiprazole |
| US20070149782A1 (en) * | 2005-12-23 | 2007-06-28 | Michael Brand | Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole |
| US20070238876A1 (en) * | 2006-04-10 | 2007-10-11 | Neera Tewari | Process for the preparation of aripiprazole |
| RU2497819C2 (ru) | 2007-05-21 | 2013-11-10 | Ривайва Фармасьютикалс, Инк. | Композиции, синтез и способы применения атипичных нейролептиков на основе хинолина |
| EP2299814A4 (en) | 2008-05-27 | 2011-06-15 | Reviva Pharmaceuticals Inc | COMPOSITIONS, SYNTHESIS AND METHOD FOR USE OF ANTIPSYCHOTICS ON PIPERAZINE BASIS |
| CN101781246B (zh) * | 2009-01-15 | 2012-02-29 | 成都康弘药业集团股份有限公司 | 一种合成阿立哌唑的改进方法 |
| KR101705727B1 (ko) | 2009-02-26 | 2017-02-10 | 레비바 파마슈티칼스, 아이엔씨. | 아릴피페라진 유도체의 조성물, 합성, 및 사용 방법 |
| JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
| WO2016181406A1 (en) * | 2015-05-08 | 2016-11-17 | Davuluri Ramamohan Rao | Improved process for the preparation of aripiprazole with reduced particle size |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| DE3034237A1 (de) † | 1979-09-18 | 1981-04-16 | Otsuka Pharmaceutical Co. Ltd., Tokyo | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel |
| US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| JP2608788B2 (ja) * | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神分裂病治療剤 |
| JP4060523B2 (ja) † | 1999-11-24 | 2008-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体の製造法 |
| AR033485A1 (es) † | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
-
2003
- 2003-12-18 CA CA002458929A patent/CA2458929C/en not_active Expired - Fee Related
- 2003-12-18 CA CA002676216A patent/CA2676216A1/en not_active Abandoned
- 2003-12-18 ES ES03780889T patent/ES2250919T5/es not_active Expired - Lifetime
- 2003-12-18 AT AT03780889T patent/ATE308524T1/de active
- 2003-12-18 BR BR0305500-0A patent/BR0305500A/pt not_active IP Right Cessation
- 2003-12-18 MX MXPA04002519A patent/MXPA04002519A/es active IP Right Grant
- 2003-12-18 AU AU2003288755A patent/AU2003288755C1/en not_active Ceased
- 2003-12-18 KR KR1020047003990A patent/KR100583667B1/ko active IP Right Grant
- 2003-12-18 TW TW092135997A patent/TWI258470B/zh not_active IP Right Cessation
- 2003-12-18 BR BRPI0305500-0A patent/BRPI0305500B1/pt unknown
- 2003-12-18 SI SI200330153T patent/SI1480953T2/sl unknown
- 2003-12-18 WO PCT/JP2003/016256 patent/WO2004063162A1/en active IP Right Grant
- 2003-12-18 DE DE60302139T patent/DE60302139T3/de not_active Expired - Lifetime
- 2003-12-18 EP EP03780889A patent/EP1480953B2/en not_active Expired - Lifetime
- 2003-12-18 DK DK03780889.6T patent/DK1480953T4/da active
-
2004
- 2004-01-05 AR ARP040100006A patent/AR042702A1/es not_active Application Discontinuation
- 2004-01-05 EG EG2004010004A patent/EG23557A/xx active
- 2004-01-08 MY MYPI20040043A patent/MY129831A/en unknown
- 2004-01-08 US US10/752,490 patent/US6995264B2/en active Active
- 2004-01-09 CN CNB2004100020641A patent/CN1263742C/zh not_active Expired - Lifetime
-
2005
- 2005-07-11 HK HK05105804A patent/HK1073110A1/xx not_active IP Right Cessation
-
2011
- 2011-11-04 JP JP2011241871A patent/JP5797090B2/ja not_active Expired - Lifetime
-
2014
- 2014-03-06 JP JP2014043786A patent/JP2014148511A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR042702A1 (es) | Proceso para preparar aripiprazola | |
| NO20062905L (no) | Nye hydroksaminsyreestere og farmasoytisk anvendelse derav | |
| PE20140192A1 (es) | Derivados de bencimidazol como inhibidores de cinasa pi3 | |
| PE20110419A1 (es) | Compuestos de pirrolo-pirimidina como inhibidores de cdk | |
| TN2015000293A1 (en) | Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
| DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
| NZ601483A (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| AR094918A1 (es) | Compuestos de tetrahidropirrolotiazina como inhibidores de bace | |
| SE9904176D0 (sv) | New use | |
| NO20056007L (no) | Dobbel NK1/NK3 antagonister for behandling av schizofreni | |
| NZ608120A (en) | Deuterated analogs of pridopidine useful as dopaminergic stabilizers | |
| BRPI0409198A (pt) | derivados quinolin-2-ona para o tratamento de doenças de vias aéreas | |
| AR055563A1 (es) | Compuestos de piridil acido acetico, agente farmaceutico y utilizacion del compuesto para preparar dicho agente | |
| AR070487A1 (es) | Derivados de 3- metil- imidazo -( 1,2-b)- piridazina | |
| BRPI0412347A (pt) | 2-aminofenil-4-fenilpiridinas como inibidores de quinase | |
| PE20020721A1 (es) | Derivados de quinuclidina como agentes antimuscarinicos m3 | |
| CY1107853T1 (el) | Χρησεις αντισπασμωδικων αμινοξεων για τη θεραπευτικη αγωγη διπολικων διαταραχων | |
| UY29301A1 (es) | Derivados amida | |
| GB0112348D0 (en) | Compounds | |
| MD3532067T2 (ro) | Formă farmaceutică lipozomală pentru utilizare în tratamentul cancerului | |
| SE0202429D0 (sv) | Novel Compounds | |
| EA200971086A1 (ru) | Фармацевтические композиции и способ лечения шизофрении | |
| RU2011153353A (ru) | Кетолидные соединения, обладающие противомикробной активностью | |
| MX2012006026A (es) | Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus. | |
| CY1119296T1 (el) | Ενωση δικαρβοξυλικου οξεος |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed, e.g., due to non-payment of fee |